Literature DB >> 18518735

Cerebellar hemorrhage and subsequent venous infarction followed by incomplete transvenous embolization of dural carotid cavernous fistulas: a rare complication: case report.

Reng-Jye Lee1, Chih-Feng Chen, Shih-Wei Hsu, Chun-Chung Lui, Yeh-Lin Kuo.   

Abstract

Endovascular therapy for dural carotid cavernous fistulas (CCFs) is generally accepted to be safe and effective. The authors report a rare complication of hemorrhage and subsequent venous infarcts of the pons and cerebellum after transvenous embolization. This 41-year-old man presented with a severe left frontal headache, congestion of the left conjunctiva, blurred vision, and photophobia. Cerebral angiography demonstrated a right dural CCF. The patient underwent transvenous embolization of the cavernous sinus but had the initial complication of cerebellar hemorrhage. One month later, he developed progressive dizziness, ataxia, and right-sided weakness. Magnetic resonance imaging revealed severe cerebellar and pontine edema. The cause was a residual fistula combined with delayed occlusion of the inferior petrosal sinus. The fistula was obliterated after repeated embolizations. The patient's symptoms gradually resolved, and there was no evidence of recurrence during the 4-year follow-up period. Incomplete transvenous embolization of a dural CCF can result in life-threatening vascular complications due to redistribution of shunt flow. Early recognition of redistributed drainage and preventive placement of coils at the origin of draining veins during the procedure could avert this rare complication.

Entities:  

Mesh:

Year:  2008        PMID: 18518735     DOI: 10.3171/JNS/2008/108/6/1245

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

1.  Brainstem congestion due to carotid-cavernous fistula via a shunt from the external carotid artery.

Authors:  Yoko Ito; Nobuo Sanjo; Kinya Ishikawa; Osamu Tao; Takanori Yokota; Hidehiro Mizusawa
Journal:  J Neurol       Date:  2011-05-24       Impact factor: 4.849

2.  De novo aneurysm formation of a feeder artery after embolization of a dural arteriovenous fistula and rupture during second embolization.

Authors:  Shouyuan Sun; Yongping Ji; Wenjun Ji; Aihua Liu; Zhongxue Wu
Journal:  Interv Neuroradiol       Date:  2018-05-22       Impact factor: 1.610

3.  Study on inferior petrosal sinus and its confluence pattern with relevant veins by MSCT.

Authors:  Weiguo Zhang; Yingying Ye; Jinhua Chen; Yi Wang; Rong Chen; Kunlin Xiong; Xue Li; Shaoxiang Zhang
Journal:  Surg Radiol Anat       Date:  2009-12-12       Impact factor: 1.246

4.  Resolution of clinical symptoms after reopening of an occluded inferior petrosal sinus in a patient with a cavernous sinus dural arteriovenous fistula. A case report.

Authors:  A Kojima; S Onozuka; Y Kinoshita
Journal:  Interv Neuroradiol       Date:  2013-03-04       Impact factor: 1.610

5.  Transvenous embolization of a carotid cavernous fistula complicated by a hematoma at the tentorial edge.

Authors:  Humain Baharvahdat; Mahmoud M Shabestari; Samira Zabihyan; Hamid Etemadresaei; Raphäel Blanc; Michel Piotin
Journal:  Interv Neuroradiol       Date:  2014-06-17       Impact factor: 1.610

6.  Transvenous retrograde AVM embolization: Indications, techniques, complications and outcomes.

Authors:  Xianli Lv; Cao Song; Hongwei He; Chuhan Jiang; Youxiang Li
Journal:  Interv Neuroradiol       Date:  2017-07-04       Impact factor: 1.610

7.  A rare brainstem hemorrhage due to incomplete transvenous embolization of the cavernous sinus dural arteriovenous fistula: A case report.

Authors:  Yoshiki Mochizuki; Satoshi Iihoshi; Eisuke Tsukagoshi; Shigen Kasakura; Shinya Kohyama; Hiroki Kurita
Journal:  Radiol Case Rep       Date:  2021-07-05

Review 8.  Dural Venous System in the Cavernous Sinus: A Literature Review and Embryological, Functional, and Endovascular Clinical Considerations.

Authors:  Yutaka Mitsuhashi; Koji Hayasaki; Taichiro Kawakami; Takashi Nagata; Yuta Kaneshiro; Ryoko Umaba; Kenji Ohata
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-04-11       Impact factor: 1.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.